NewAmsterdam Pharma N.V. (NAMS)
23.95
0.28 (1.18%)
At close: Jan 15, 2025, 12:58 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Cash & Equivalents | 340.45M | 438.52M | 53.09M | 7.86M |
| Short-Term Investments | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | 718.35K | 112.79M |
| Other Long-Term Assets | 35.00K | 146.00K | -353 | -112.79M |
| Receivables | 1.88M | 2.07M | 4.86M | n/a |
| Inventory | n/a | 21.50K | -735 | n/a |
| Other Current Assets | 4.46M | 8.18M | 7.47M | 1.67M |
| Total Current Assets | 346.79M | 448.13M | 58.87M | 9.22M |
| Property-Plant & Equipment | 101.00K | 144.00K | 190.00K | 12.00K |
| Goodwill & Intangibles | 170.00K | 83.16M | n/a | n/a |
| Total Long-Term Assets | 306.00K | 83.45M | 908.00K | 12.00K |
| Total Assets | 347.10M | 531.58M | 59.78M | 9.23M |
| Account Payables | 16.92M | 11.85M | 7.04M | 487.06K |
| Deferred Revenue | 8.94M | 13.01M | 3.61M | n/a |
| Short-Term Debt | 60.00K | 66.00K | 60.01K | 11.65M |
| Other Current Liabilities | 23.97M | 9.67M | 1.31M | 670.94K |
| Total Current Liabilities | 49.90M | 35.46M | 9.88M | 12.81M |
| Long-Term Debt | n/a | 60.00K | 125.68K | n/a |
| Other Long-Term Liabilities | 7.79M | 6.75M | -14.68K | n/a |
| Total Long-Term Liabilities | 8.81M | 11.60M | 111.00K | 9.95M |
| Total Liabilities | 58.70M | 47.06M | 9.99M | 12.81M |
| Total Debt | 60.00K | 118.00K | 164.00K | 11.65M |
| Common Stock | 10.17M | 599.19M | 83.88M | 2.50M |
| Retained Earnings | -316.97M | -119.36M | -34.68M | -6.08M |
| Comprehensive Income | 4.42M | 4.69M | 591.00K | n/a |
| Shareholders Equity | 288.39M | 484.52M | 49.79M | -3.58M |
| Total Investments | -31.08M | n/a | 718.35K | 112.79M |